← Back to Screener
Alpha Cognition Inc. Common Stock (ACOG)
Price$5.82
Value ScoreC
Growth ScoreB
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-14.34%
Price vs S&P 500 (4W)-6.44%
VGM Score52.03
Market Capitalization$126.73M
All Metrics
Book Value / Share (Quarterly)$2.64
P/TBV (Annual)2.27x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-1.39
Price vs S&P 500 (YTD)-20.10%
Gross Margin (TTM)84.42%
Net Profit Margin (TTM)-232.24%
EPS (TTM)$-1.34
10-Day Avg Trading Volume0.03M
EPS Excl Extra (TTM)$-1.34
EPS (Annual)$-1.17
ROI (Annual)-33.06%
Gross Margin (Annual)81.26%
Cash / Share (Quarterly)$2.49
Revenue Growth QoQ (YoY)20.66%
ROA (Last FY)-25.92%
EBITD / Share (TTM)$-1.41
Operating Margin (TTM)-250.06%
Cash Flow / Share (Annual)$-0.95
P/B Ratio2.21x
P/B Ratio (Quarterly)2.08x
Net Income / Employee (Annual)$-291,100
EV / Revenue (TTM)6.70x
Net Interest Coverage (TTM)-3.45x
ROA (TTM)-41.83%
EPS Incl Extra (Annual)$-1.17
Current Ratio (Annual)8.65x
Quick Ratio (Quarterly)10.67x
3-Month Avg Trading Volume0.06M
52-Week Price Return-38.28%
Revenue / Employee (TTM)$152,500
Tangible BV / Share (Quarterly)$2.62
P/S Ratio (Annual)12.40x
Asset Turnover (Annual)0.13x
52-Week High$11.54
EPS Excl Extra (Annual)$-1.17
26-Week Price Return-2.96%
Quick Ratio (Annual)7.70x
13-Week Price Return0.85%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)12.64x
Enterprise Value$72.48M
Asset Turnover (TTM)0.18x
Revenue / Employee (Annual)$143,900
Pretax Margin (Annual)-202.24%
Cash / Share (Annual)$3.04
3-Month Return Std Dev61.35%
Net Income / Employee (TTM)$-354,100
ROE (Last FY)-33.06%
EPS Basic Excl Extra (Annual)$-1.17
Receivables Turnover (TTM)5.41x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-1.34
ROI (TTM)-54.13%
P/S Ratio (TTM)11.71x
Revenue / Share (Annual)$0.58
Tangible BV / Share (Annual)$2.86
Price vs S&P 500 (52W)-65.32%
Year-to-Date Return-9.08%
5-Day Price Return-4.52%
EPS Normalized (Annual)$-1.17
Net Profit Margin (Annual)-202.24%
Month-to-Date Return-4.52%
EBITD / Share (Annual)$-1.28
Operating Margin (Annual)-221.72%
EPS Basic Excl Extra (TTM)$-1.34
P/TBV (Quarterly)2.09x
P/B Ratio (Annual)2.26x
Inventory Turnover (TTM)0.49x
Pretax Margin (TTM)-232.24%
Book Value / Share (Annual)$2.88
Price vs S&P 500 (13W)-9.65%
Beta8.71x
Revenue / Share (TTM)$0.50
ROE (TTM)-54.13%
52-Week Low$4.50
vGradeC
gGradeB
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.32est. -0.39
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.14
4.14
4.13
4.11
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ACOGAlpha Cognition Inc. Common Stock | C | B | C | $5.82 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
Alpha Cognition Inc is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases, including Alzheimer's disease. The company markets ZUNVEYL, an oral tablet formulation, and is building a commercial team targeting the long-term care market with a focus on positioning ZUNVEYL against existing acetylcholinesterase inhibitor treatments. The company is also pursuing licensing partnerships to expand ZUNVEYL's indications and formulations.